Table 4 –

Propensity score weighted multivariate analysis of long-term clinical outcomes compared with dual-goal and single-goal achievers.

Complications/death	Ale + BP vs A1e		Ale + BP vs BP		A1e + LDL-C vs A1e		A1e + LDL-C vs LDL-C		LDL-C + BP vs LDL-C		LDL-C + BP vs BP
	aHR*	95% CI	aHR*	95% CI	aHR*	95% CI	aHR*	95% CI	aHR*	95% CI	aHR*	95% CI
Microvascular complications	1.005	(0.988, 1.021)	0.996	(0.983, 1.009)	0.986	(0.969, 1.003)	1.008	(0.993, 1.023)	1.003	(0.991, 1.016)	0.973	(0.962, 0.984)
Macrovascular complications	0.996	(0.980, 1.013)	0.982	(0.969, 0.995)	0.974	(0.958, 0.992)	0.990	(0.975, 1.005)	1.000	(0.988, 1.012)	0.970	(0.959, 0.981)
Myocardial infarction	0.995	(0.979, 1.011)	0.988	(0.976, 1.001)	0.978	(0.962, 0.995)	1.000	(0.985, 1.014)	0.997	(0.985, 1.009)	0.969	(0.959, 0.980)
Cerebrovascular disease	0.999	(0.983, 1.016)	0.987	(0.975, 1.000)	0.978	(0.961, 0.995)	0.997	(0.983, 1.011)	1.001	(0.989, 1.013)	0.970	(0.959, 0.981)
Acute coronary syndromes	0.995	(0.979, 1.011)	0.989	(0.977, 1.001)	0.978	(0.961, 0.994)	0.999	(0.985, 1.014)	0.997	(0.985, 1.008)	0.970	(0.959, 0.980)
Congestive heart failure	0.994	(0.978, 1.010)	0.989	(0.976, 1.001)	0.975	(0.959, 0.992)	1.001	(0.986, 1.015)	0.998	(0.986, 1.010)	0.967	(0.956, 0.978)
All-cause death	0.996	(0.980, 1.012)	0.988	(0.976, 1.001)	0.978	(0.962, 0.995)	0.998	(0.983, 1.012)	0.995	(0.984, 1.007)	0.969	(0.958, 0.980)

^*aHR: Adjusted Hazard Ratio; compared with Triple-goal achievers to other goal achievement which were associated with higher risk for complications/all-cause mortality.